Phase Ib trial combining capecitabine, erlotinib and bevacizumab in pancreatic adenocarcinoma - REBECA trial

Investigational New Drugs
Christian DittrichPhilipp Buchner

Abstract

Background Purpose of this phase Ib trial was to establish the maximum tolerable dose (MTD) of capecitabine and to escalate the dosages of erlotinib and bevacizumab to determine the recommended phase II dose (RP2D) in patients with advanced/metastatic pancreatic adenocarcinoma not pretreated for metastatic disease. Methods Starting doses were capecitabine 500 mg/m2 bid orally continuously, erlotinib 100 mg orally daily, and bevacizumab 5 mg/kg intravenously q 2 weeks. Dose escalation was performed according to a 3 + 3 design for capecitabine until MTD, for erlotinib and bevacizumab until the maximum doses registered by applying a substance-related, toxicity-based scheme accompanied by pharmacokinetic analysis. Circulating tumor cells (CTCs) were determined pretherapeutically by immunohistochemical identification after enrichment with immunomagnetic separation. Results Thirty patients were evaluable at six dose levels. 900 mg/m2 bid were determined as MTD for capecitabine based on dose-limiting toxicities: cutaneous in two patients and vascular in another. The most severe (Grade (G)3/4) drug-related treatment-emergent adverse events (toxicities) belonged to the categories gastrointestinal, vascular, cutaneous, cardiovascular, me...Continue Reading

References

Jun 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·H A BurrisD D Von Hoff
Jan 24, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·UNKNOWN Meta-analysis Group In CancerE Levy
May 20, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D R BudmanT Griffin
Mar 15, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·E Van CutsemJ Verweij
May 15, 2002·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Y D JungL M Ellis
Jan 31, 2003·Molecular Cancer·M Korc
Oct 14, 2003·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Erin R LepperAlex Sparreboom
Jun 29, 2005·Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [et Al.]·Dongming SuMasao Tanaka
Sep 2, 2005·Journal of Cancer Research and Clinical Oncology·Edlyn SoethIlka Vogel
Nov 1, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Hedy L KindlerEverett E Vokes
Apr 25, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Malcolm J MooreUNKNOWN National Cancer Institute of Canada Clinical Trials Group
Jun 1, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Stephen A Welch, Malcolm J Moore
Oct 20, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Matthew H KulkeCharles S Fuchs
Nov 8, 2007·Annals of Oncology : Official Journal of the European Society for Medical Oncology·E Van CutsemJ-P Delord
Feb 6, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Chris TwelvesJosé Baselga
Feb 15, 2008·CA: a Cancer Journal for Clinicians·Matthew H G KatzDouglas B Evans
Apr 12, 2008·Nature Reviews. Cancer·Klaus PantelBurkhard Brandt
Mar 25, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Eric Van CutsemMalcolm J Moore
Oct 28, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Naureen StarlingIan Chau
Feb 5, 2010·Cancer Chemotherapy and Pharmacology·Andrew H KoMargaret A Tempero
Jul 8, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Hedy Lee KindlerRichard M Goldberg
Jan 5, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M A TemperoE Van Cutsem
May 13, 2011·The New England Journal of Medicine·Thierry ConroyUNKNOWN PRODIGE Intergroup
Jun 18, 2011·Critical Reviews in Oncology/hematology·F C BidardJ Y Pierga
Mar 1, 2013·International Journal of Cancer. Journal International Du Cancer·Kjersti TjensvollRune Smaaland
Apr 3, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Hideki UenoMasao Tanaka
May 7, 2013·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Philippe RougierPhilip A Philip
May 17, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·F C BidardP Hammel
Aug 1, 2013·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Michele ReniEugenio Villa
Sep 12, 2013·British Journal of Cancer·S G LouieC D Blanke
Oct 18, 2013·The New England Journal of Medicine·Daniel D Von HoffMarkus F Renschler
Nov 13, 2013·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Lu HanQicheng Zhao
Aug 16, 2014·Asian Pacific Journal of Cancer Prevention : APJCP·Xue-Lei MaPing Li
Jun 23, 2016·Cancer Chemotherapy and Pharmacology·Kelong HanJin Jin
Apr 5, 2017·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Susan E Bates
Apr 5, 2017·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Stephan B DreyerAndrew V Biankin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Adhesion Molecules in the Brain

Cell adhesion molecules found on cell surface help cells bind with other cells or the extracellular matrix to maintain structure and function. Here is the latest research on their role in the brain.

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.